5-aminosalicylic acid

RX_A07EC02

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC A07EC02

8728

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

6759

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

6759

diagram downward connector

Include endpoints None

6759

diagram downward connector
RX_A07EC02

Extra metadata

First used in FinnGen datafreeze DF4

Summary Statistics

Key figures

All Female Male
Number of individuals 6759 3635 3124
Unadjusted prevalence (%) 1.90 1.83 1.99
Mean age at first event (years) 42.67 40.77 44.87

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.41 [1.01, 1.95] 4.2e-2 407
15 years 0.01 1.02 [0.77, 1.36] 8.7e-1 186
5 years 0.00 1.94 [1.47, 2.56] 2.7e-6 96
1 year 0.00 2.00 [1.21, 3.29] 6.6e-3 18

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: RX_A07EC02 – 5-aminosalicylic acid
GWS hits:

Survival analyses between endpoints

Plot

before 5-aminosalicylic acid
after 5-aminosalicylic acid

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after 5-aminosalicylic acid